Switch to Rilpivirine/Emtricitabine/Tenofovir Single-Tablet Regimen of Human Immunodeficiency Virus-1 RNA-Suppressed Patients, Agence Nationale de Recherches sur le SIDA et les Hépatites Virales CO3 Aquitaine Cohort, 2012–2014

Background. The purpose of this study was to assess the efficacy and tolerability of combined antiretroviral therapy (cART) in human immunodeficiency virus (HIV)-1 virologically suppressed patients who switched to rilpivirine (RPV)/tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) as a single-...

Descripción completa

Detalles Bibliográficos
Autores principales: Cazanave, Charles, Reigadas, Sandrine, Mazubert, Cyril, Bellecave, Pantxika, Hessamfar, Mojgan, Le Marec, Fabien, Lazaro, Estibaliz, Peytavin, Gilles, Bruyand, Mathias, Fleury, Hervé, Dabis, François, Neau, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438898/
https://www.ncbi.nlm.nih.gov/pubmed/26034768
http://dx.doi.org/10.1093/ofid/ofv018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438898/
https://www.ncbi.nlm.nih.gov/pubmed/26034768
http://dx.doi.org/10.1093/ofid/ofv018

Ejemplares similares